Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.

Dowling CM, Assel M, Musser JE, Meeks JJ, Sjoberg D, Bosl G, Motzer R, Bajorin D, Feldman D, Carver BS, Sheinfeld J.

Urology. 2018 Feb 1. pii: S0090-4295(18)30049-9. doi: 10.1016/j.urology.2018.01.014. [Epub ahead of print]

PMID:
29410311
2.

A Laparoscopic Approach is Best for Retroperitoneal Lymph Node Dissection: No.

Sheinfeld J, Masterson TA.

J Urol. 2017 Jun;197(6):1384-1386. doi: 10.1016/j.juro.2017.03.064. Epub 2017 Apr 22. No abstract available.

PMID:
28442220
3.

Malignant Mesothelioma of the Tunica Vaginalis Testis: Outcomes Following Surgical Management Beyond Radical Orchiectomy.

Recabal P, Rosenzweig B, Bazzi WM, Carver BS, Sheinfeld J.

Urology. 2017 Sep;107:166-170. doi: 10.1016/j.urology.2017.04.011. Epub 2017 Apr 14.

PMID:
28416299
4.

Editorial Comment.

Pietzak EJ, Becerra MF, Sheinfeld J.

Urology. 2017 Apr;102:162. doi: 10.1016/j.urology.2016.08.064. Epub 2016 Dec 26. No abstract available.

PMID:
28034529
5.

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

O'Shaughnessy MJ, McBride SM, Vargas HA, Touijer KA, Morris MJ, Danila DC, Laudone VP, Bochner BH, Sheinfeld J, Dayan ES, Bellomo LP, Sjoberg DD, Heller G, Zelefsky MJ, Eastham JA, Scardino PT, Scher HI.

Urology. 2017 Apr;102:164-172. doi: 10.1016/j.urology.2016.10.044. Epub 2016 Nov 22.

6.

Editorial Comment.

Pietzak EJ, Becerra MF, Sheinfeld J.

Urology. 2017 Jan;99:173. doi: 10.1016/j.urology.2016.04.062. Epub 2016 Nov 7. No abstract available.

PMID:
27829530
7.

Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.

Kopp RP, Chevinsky M, Bernstein M, Bosl G, Motzer R, Bajorin D, Feldman D, Carver BS, Sheinfeld J.

Urology. 2017 May;103:154-160. doi: 10.1016/j.urology.2016.10.018. Epub 2016 Nov 2.

PMID:
27816603
8.

Retroperitoneal Lymph Node Dissection: Anatomical and Technical Considerations from a Cadaveric Study.

Beveridge TS, Allman BL, Johnson M, Power A, Sheinfeld J, Power NE.

J Urol. 2016 Dec;196(6):1764-1771. doi: 10.1016/j.juro.2016.06.091. Epub 2016 Jul 5.

9.

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.

Mano R, Becerra MF, Carver BS, Bosl GJ, Motzer RJ, Bajorin DF, Feldman DR, Sheinfeld J.

J Urol. 2017 Feb;197(2):391-397. doi: 10.1016/j.juro.2016.09.113. Epub 2016 Oct 5.

10.

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

Bagrodia A, Lee BH, Lee W, Cha EK, Sfakianos JP, Iyer G, Pietzak EJ, Gao SP, Zabor EC, Ostrovnaya I, Kaffenberger SD, Syed A, Arcila ME, Chaganti RS, Kundra R, Eng J, Hreiki J, Vacic V, Arora K, Oschwald DM, Berger MF, Bajorin DF, Bains MS, Schultz N, Reuter VE, Sheinfeld J, Bosl GJ, Al-Ahmadie HA, Solit DB, Feldman DR.

J Clin Oncol. 2016 Nov 20;34(33):4000-4007. doi: 10.1200/JCO.2016.68.7798. Epub 2016 Sep 30.

11.

The Evolving Management of Patients With Clinical Stage I Seminoma.

Matulewicz RS, Oberlin DT, Sheinfeld J, Meeks JJ.

Urology. 2016 Dec;98:113-119. doi: 10.1016/j.urology.2016.07.037. Epub 2016 Aug 12.

12.

Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience.

Alanee SR, Carver BS, Feldman DR, Motzer RJ, Bosl GJ, Sheinfeld J.

Urology. 2016 Sep;95:128-31. doi: 10.1016/j.urology.2016.05.014. Epub 2016 May 25.

13.

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.

Feldman DR, Hu J, Dorff TB, Lim K, Patil S, Woo KM, Carousso M, Hughes A, Sheinfeld J, Bains M, Daneshmand S, Ketchens C, Bajorin DF, Bosl GJ, Quinn DI, Motzer RJ.

J Clin Oncol. 2016 Jul 20;34(21):2478-83. doi: 10.1200/JCO.2016.66.7899. Epub 2016 May 16.

14.

Are Some Cases of Somatic Type Malignancy Potentially Avoidable?

Sheinfeld J, Becerra MF, Feldman DR.

J Urol. 2016 Jul;196(1):11-3. doi: 10.1016/j.juro.2016.04.044. Epub 2016 Apr 13. No abstract available.

PMID:
27086183
15.

Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer Patients.

Yarmohammadi H, Brody LA, Erinjeri JP, Covey AM, Boas FE, Ziv E, Maybody M, Gonzalez-Aguirre AJ, Brown KT, Sheinfeld J, Getrajdman GI.

J Vasc Interv Radiol. 2016 May;27(5):665-73. doi: 10.1016/j.jvir.2015.12.014. Epub 2016 Mar 7.

16.

Late Relapse of Testicular Germ Cell Tumors.

O'Shaughnessy MJ, Feldman DR, Carver BS, Sheinfeld J.

Urol Clin North Am. 2015 Aug;42(3):359-68. doi: 10.1016/j.ucl.2015.04.010. Epub 2015 Jun 16. Review.

PMID:
26216823
17.

Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach.

Beard CJ, Gupta S, Motzer RJ, O'Donnell EK, Plimack ER, Margolin KA, Ryan CJ, Sheinfeld J, Feldman DR.

J Natl Compr Canc Netw. 2015 Jun;13(6):811-22. Review.

PMID:
26085395
18.

Testicular Cancer, Version 2.2015.

Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R.

J Natl Compr Canc Netw. 2015 Jun;13(6):772-99.

PMID:
26085393
19.

Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.

Feldman DR, Glezerman I, Patil S, Van Alstine L, Bajorin DF, Fischer P, Hughes A, Sheinfeld J, Bains M, Reich L, Woo K, Giralt S, Bosl GJ, Motzer RJ.

Clin Genitourin Cancer. 2015 Oct;13(5):453-60. doi: 10.1016/j.clgc.2015.05.003. Epub 2015 May 16.

20.

Kidney cancer, version 3.2015.

Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Feb;13(2):151-9.

PMID:
25691606
21.

Editorial comment.

Sheinfeld J, Feldman DR.

Urology. 2014 Oct;84(4):890-1. doi: 10.1016/j.urology.2014.05.056. No abstract available.

PMID:
25260451
22.

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

Kundu SD, Feldman DR, Carver BS, Gupta A, Bosl GJ, Motzer RJ, Bajorin DF, Sheinfeld J.

J Urol. 2015 Feb;193(2):513-8. doi: 10.1016/j.juro.2014.08.081. Epub 2014 Aug 20.

23.

Kidney cancer, version 2.2014.

Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Sircar K, Somer B, Wang J, Wilder RB, Dwyer MA, Kumar R; Natiomal compresensive cancer networks.

J Natl Compr Canc Netw. 2014 Feb;12(2):175-82.

PMID:
24586079
24.

Clinical outcomes of local and metastatic testicular sex cord-stromal tumors.

Silberstein JL, Bazzi WM, Vertosick E, Carver BS, Bosl GJ, Feldman DR, Bajorin DF, Motzer RJ, Al-Ahmadie H, Reuter VE, Sheinfeld J.

J Urol. 2014 Aug;192(2):415-9. doi: 10.1016/j.juro.2014.01.104. Epub 2014 Feb 8.

PMID:
24518791
25.

Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy.

Al-Ahmadie HA, Carver BS, Cronin AM, Olgac S, Tickoo SK, Fine SW, Gopalan A, Stasi J, Rabbani F, Bosl GJ, Sheinfeld J, Reuter VE.

Urology. 2013 Dec;82(6):1341-6. doi: 10.1016/j.urology.2013.04.082. Epub 2013 Oct 2.

PMID:
24094656
26.

Reply: To PMID 24094653.

Al-Ahmadie H, Sheinfeld J, Bosl GJ, Reuter VE.

Urology. 2013 Dec;82(6):1346-7. doi: 10.1016/j.urology.2013.04.084. Epub 2013 Oct 2. No abstract available.

PMID:
24094654
27.

Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.

Feldman DR, Voss MH, Jacobsen EP, Jia X, Suarez JA, Turkula S, Sheinfeld J, Bosl GJ, Motzer RJ, Patil S.

Cancer. 2013 Jul 15;119(14):2574-81. doi: 10.1002/cncr.28025. Epub 2013 Apr 19.

28.

Rare de novo germline copy-number variation in testicular cancer.

Stadler ZK, Esposito D, Shah S, Vijai J, Yamrom B, Levy D, Lee YH, Kendall J, Leotta A, Ronemus M, Hansen N, Sarrel K, Rau-Murthy R, Schrader K, Kauff N, Klein RJ, Lipkin SM, Murali R, Robson M, Sheinfeld J, Feldman D, Bosl G, Norton L, Wigler M, Offit K.

Am J Hum Genet. 2012 Aug 10;91(2):379-83. doi: 10.1016/j.ajhg.2012.06.019. Epub 2012 Aug 2.

29.

Testicular cancer.

Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Apr;10(4):502-35. No abstract available.

PMID:
22491049
30.

Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

Masterson TA, Carver BS, Shayegan B, Feldman DR, Motzer RJ, Bosl GJ, Sheinfeld J.

Urology. 2012 May;79(5):1079-84. doi: 10.1016/j.urology.2011.11.090. Epub 2012 Mar 23.

PMID:
22446341
31.

Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour.

Masterson TA, Carver BS, Abel EJ, Pettus JA, Bosl GJ, Sheinfeld J.

BJU Int. 2012 Oct;110(7):950-5. doi: 10.1111/j.1464-410X.2012.10947.x. Epub 2012 Mar 6.

32.

Environmental toxicology of testicular cancer.

Meeks JJ, Sheinfeld J, Eggener SE.

Urol Oncol. 2012 Mar-Apr;30(2):212-5. doi: 10.1016/j.urolonc.2011.09.009. Review.

PMID:
22385991
33.

Editorial comment.

Sheinfeld J.

Urology. 2012 Feb;79(2):370; author reply 371. doi: 10.1016/j.urology.2011.09.047. No abstract available.

PMID:
22310753
34.

Cervical metastasis of germ cell tumors: evaluation, management, complications, and outcomes.

Mehra S, Liu J, Gupta A, Sheinfeld J, Kraus D.

Laryngoscope. 2012 Feb;122(2):286-90. doi: 10.1002/lary.22422. Epub 2012 Jan 17.

PMID:
22252920
35.

Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer.

Masterson TA, Shayegan B, Carver BS, Bajorin DF, Feldman DR, Motzer RJ, Bosl GJ, Sheinfeld J.

Urology. 2012 Jan;79(1):156-9. doi: 10.1016/j.urology.2011.09.038.

PMID:
22202548
36.

Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection.

Thompson RH, Carver BS, Bosl GJ, Bajorin D, Motzer R, Feldman D, Reuter VE, Sheinfeld J.

Urology. 2012 Feb;79(2):361-4. doi: 10.1016/j.urology.2011.04.050. Epub 2011 Dec 14.

37.

The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation.

Daneshmand S, Stephenson AJ, Sheinfeld J, Jewett MA.

Urol Oncol. 2011 Nov-Dec;29(6):842-7. doi: 10.1016/j.urolonc.2011.05.018.

PMID:
22078409
38.

The role of lymphadenectomy for testicular cancer: indications, controversies, and complications.

Tarin T, Carver B, Sheinfeld J.

Urol Clin North Am. 2011 Nov;38(4):439-49, vi. doi: 10.1016/j.ucl.2011.07.010. Review.

PMID:
22045175
40.

Kidney cancer.

Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Carducci MA, Chang SS, Choueiri TK, Hancock SL, Hudes GR, Jonasch E, Josephson D, Kuzel TM, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Spiess PE, Wang J, Wilder RB; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Sep 1;9(9):960-77. No abstract available. Erratum in: J Natl Compr Canc Netw. 2011 Nov 1;9(11):xlv.

PMID:
21917622
41.

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.

Feldman DR, Patil S, Trinos MJ, Carousso M, Ginsberg MS, Sheinfeld J, Bajorin DF, Bosl GJ, Motzer RJ.

Cancer. 2012 Feb 15;118(4):981-6. doi: 10.1002/cncr.26375. Epub 2011 Jul 26.

42.

Retroperitoneal histologic findings of patients with elevated serum alpha-fetoprotein and pure seminoma at orchiectomy.

Kundu SD, Carver BS, Sheinfeld J.

Urology. 2011 Oct;78(4):844-7. doi: 10.1016/j.urology.2011.02.002. Epub 2011 Jul 22.

43.

Postchemotherapy surgery for germ cell tumors of the testis.

Carver BS, Sheinfeld J.

Curr Opin Oncol. 2011 May;23(3):271-4. doi: 10.1097/CCO.0b013e32834579d9. Review.

PMID:
21415749
44.

Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.

Gupta A, Feifer AH, Gotto GT, Kraus D, Motzer R, Bosl GJ, Bajorin D, Feldman DR, Carver B, Sheinfeld J.

Urology. 2011 Mar;77(3):655-9. doi: 10.1016/j.urology.2010.10.002.

PMID:
21377010
45.

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

Thompson RH, Carver BS, Bosl GJ, Bajorin D, Motzer R, Feldman DR, Reuter VE, Sheinfeld J.

Urology. 2011 Feb;77(2):368-72. doi: 10.1016/j.urology.2010.05.020. Epub 2010 Dec 15.

46.

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.

Thompson RH, Carver BS, Bosl GJ, Bajorin D, Motzer R, Feldman D, Reuter VE, Sheinfeld J.

Cancer. 2010 Nov 15;116(22):5243-50. doi: 10.1002/cncr.25266.

47.

Surgery for retroperitoneal relapse in the setting of a prior retroperitoneal lymph node dissection for germ cell tumor.

Gotto GT, Carver BS, Sogani P, Sheinfeld J.

Indian J Urol. 2010 Jan-Mar;26(1):102-7. doi: 10.4103/0970-1591.60452.

48.

The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.

Carver BS, Cronin AM, Eggener S, Savage CJ, Motzer RJ, Bajorin D, Bosl GJ, Sheinfeld J.

Urology. 2010 Jun;75(6):1431-5. doi: 10.1016/j.urology.2009.11.076. Epub 2010 Mar 17.

49.

TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, Patil S, Bains M, Reich LM, Bosl GJ, Motzer RJ.

J Clin Oncol. 2010 Apr 1;28(10):1706-13. doi: 10.1200/JCO.2009.25.1561. Epub 2010 Mar 1. Erratum in: J Clin Oncol. 2010 Dec 1;28(34):5126.

50.

Retroperitoneal lymph node dissection after chemotherapy.

Winter C, Raman JD, Sheinfeld J, Albers P.

BJU Int. 2009 Nov;104(9 Pt B):1404-12. doi: 10.1111/j.1464-410X.2009.08867.x. Review.

Supplemental Content

Loading ...
Support Center